Humanwell Healthcare (Group) Co (SHSE:600079) Piotroski F-Score: 7 (As of Jul. 13, 2026) — 17% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600079 Humanwell Healthcare (Group) Co Ltd SHSE:600079
61 GF Score
Price ¥17.55
GF Value ¥21.63
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Humanwell Healthcare (Group) Co Piotroski F-Score?

Humanwell Healthcare (Group) Co SHSE:600079 +0.98% 61 Piotroski F-Score is 7 as of Jul. 13, 2026, which is 17% above its 10-year median of 6.00. GuruFocus rates SHSE:600079 with a GF Score™ of 61/100 and a GF Value™ of ¥21.63 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 979 Drug Manufacturers companies, Humanwell Healthcare (Group) Co ranks better than 91.93% on this metric.

Good Sign:

Piotroski F-Score is 7, indicates a very healthy situation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Humanwell Healthcare (Group) Co has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

The historical rank and industry rank for Humanwell Healthcare (Group) Co's Piotroski F-Score or its related term are showing as below:

SHSE:600079' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 6   Max: 8
Current: 7

During the past 13 years, the highest Piotroski F-Score of Humanwell Healthcare (Group) Co was 8. The lowest was 3. And the median was 6.

Humanwell Healthcare (Group) Co  (SHSE:600079) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Humanwell Healthcare (Group) Co Piotroski F-Score Related Terms


Humanwell Healthcare (Group) Co Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Humanwell Healthcare (Group) Co's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Humanwell Healthcare (Group) Co Piotroski F-Score Chart

Humanwell Healthcare (Group) Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.00 6.00 6.00 7.00 7.00

Humanwell Healthcare (Group) Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.00 6.00 4.00 7.00 7.00

SHSE:600079 vs ZTS, UTHR: Piotroski F-Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Humanwell Healthcare (Group) Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Humanwell Healthcare (Group) Co Piotroski F-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Humanwell Healthcare (Group) Co's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Humanwell Healthcare (Group) Co's Piotroski F-Score falls into.


SHSE:600079
61GF Score
Humanwell Healthcare (Group) Co Ltd SHSE:600079
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was 614.321 + 533.91 + 166.758 + 588.168 = ¥1,903 Mil.
Cash Flow from Operations was 1195.171 + 789.563 + 870.769 + 280.926 = ¥3,136 Mil.
Revenue was 5926.518 + 5819.434 + 6078.658 + 6101.249 = ¥23,926 Mil.
Gross Profit was 2832.587 + 2761.888 + 2978.343 + 3022.187 = ¥11,595 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(37166.546 + 37555.135 + 36824.187 + 36745.122 + 37611.72) / 5 = ¥37180.542 Mil.
Total Assets at the begining of this year (Mar25) was ¥37,167 Mil.
Long-Term Debt & Capital Lease Obligation was ¥2,637 Mil.
Total Current Assets was ¥21,509 Mil.
Total Current Liabilities was ¥11,197 Mil.
Net Income was 624.703 + 478.599 + -259.949 + 540.345 = ¥1,384 Mil.

Revenue was 6493.912 + 6282.091 + 6292.11 + 6137.4 = ¥25,206 Mil.
Gross Profit was 3062.132 + 2934.44 + 2381.155 + 2980.156 = ¥11,358 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(36780.555 + 36580.817 + 37345.934 + 36508.324 + 37166.546) / 5 = ¥36876.4352 Mil.
Total Assets at the begining of last year (Mar24) was ¥36,781 Mil.
Long-Term Debt & Capital Lease Obligation was ¥957 Mil.
Total Current Assets was ¥20,412 Mil.
Total Current Liabilities was ¥13,664 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Humanwell Healthcare (Group) Co's current Net Income (TTM) was 1,903. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Humanwell Healthcare (Group) Co's current Cash Flow from Operations (TTM) was 3,136. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=1903.157/37166.546
=0.05120618

ROA (Last Year)=Net Income/Total Assets (Mar24)
=1383.698/36780.555
=0.03762037

Humanwell Healthcare (Group) Co's return on assets of this year was 0.05120618. Humanwell Healthcare (Group) Co's return on assets of last year was 0.03762037. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Humanwell Healthcare (Group) Co's current Net Income (TTM) was 1,903. Humanwell Healthcare (Group) Co's current Cash Flow from Operations (TTM) was 3,136. ==> 3,136 > 1,903 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=2636.817/37180.542
=0.07091927

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=957.112/36876.4352
=0.02595457

Humanwell Healthcare (Group) Co's gearing of this year was 0.07091927. Humanwell Healthcare (Group) Co's gearing of last year was 0.02595457. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=21508.733/11196.5
=1.92102291

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=20412.196/13663.998
=1.49386702

Humanwell Healthcare (Group) Co's current ratio of this year was 1.92102291. Humanwell Healthcare (Group) Co's current ratio of last year was 1.49386702. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Humanwell Healthcare (Group) Co's number of shares in issue this year was 1633.8. Humanwell Healthcare (Group) Co's number of shares in issue last year was 1637.41. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=11595.005/23925.859
=0.48462231

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=11357.883/25205.513
=0.45061106

Humanwell Healthcare (Group) Co's gross margin of this year was 0.48462231. Humanwell Healthcare (Group) Co's gross margin of last year was 0.45061106. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=23925.859/37166.546
=0.64374718

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=25205.513/36780.555
=0.68529453

Humanwell Healthcare (Group) Co's asset turnover of this year was 0.64374718. Humanwell Healthcare (Group) Co's asset turnover of last year was 0.68529453. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+1+0+1+1+1+0
=7

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Humanwell Healthcare (Group) Co has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 7 mean?
Humanwell Healthcare (Group) Co (SHSE:600079) has a Piotroski F-Score of 7 as of Jul. 13, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Humanwell Healthcare (Group) Co and its competitors. This is 17% above median its historical median of 6.00. Over the past decade, Humanwell Healthcare (Group) Co's Piotroski F-Score has ranged from 3.00 to 8.00. According to the industry distribution chart, Humanwell Healthcare (Group) Co ranks #79 out of 979 companies in the Drug Manufacturers industry, placing it in the top 8.1%.
Is Humanwell Healthcare (Group) Co's Piotroski F-Score too high?
Humanwell Healthcare (Group) Co's current Piotroski F-Score of 7 is 17% above median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 8.00. The Drug Manufacturers industry median Piotroski F-Score is 5.00. Humanwell Healthcare (Group) Co's value of 7 is 40% above this industry median. Based on the distribution chart, Humanwell Healthcare (Group) Co ranks #79 out of 979 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Humanwell Healthcare (Group) Co has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Humanwell Healthcare (Group) Co's Piotroski F-Score compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Humanwell Healthcare (Group) Co ranks #79 out of 979 companies for Piotroski F-Score. This places Humanwell Healthcare (Group) Co in the top 8% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. Humanwell Healthcare (Group) Co's value of 7 is 40% above this benchmark. Historically, Humanwell Healthcare (Group) Co's own Piotroski F-Score has ranged from 3.00 to 8.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, Humanwell Healthcare (Group) Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Drug Manufacturers company?
The median Piotroski F-Score among Drug Manufacturers companies is 5.00, based on 979 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Humanwell Healthcare (Group) Co's current Piotroski F-Score of 7 is 40% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Humanwell Healthcare (Group) Co and its competitors. For the Drug Manufacturers industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Humanwell Healthcare (Group) Co's current Piotroski F-Score is 7, which is 17% above median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Humanwell Healthcare (Group) Co stock overvalued right now?
Based on GuruFocus' analysis, Humanwell Healthcare (Group) Co (SHSE:600079) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥21.63, compared to a current price of ¥17.55 — trading 18.9% below its estimated fair value. The current Piotroski F-Score is 7, which is 17% above median its 10-year median of 6.00 and 40% above the Drug Manufacturers industry median of 5.00. Humanwell Healthcare (Group) Co's overall GF Score™ is 61/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Humanwell Healthcare (Group) Co (SHSE:600079), the current Piotroski F-Score is 7 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Humanwell Healthcare (Group) Co (SHSE:600079) Overvalued in 2026?

Based on GuruFocus' analysis, Humanwell Healthcare (Group) Co stock appears to be undervalued. The current stock price of ¥17.55 is trading 18.9% below its estimated GF Value™ of ¥21.63. GuruFocus considers Humanwell Healthcare (Group) Co to be Modestly Undervalued.

Key valuation signals for SHSE:600079:

  • Piotroski F-Score: 7 (17% above median its 10-year median of 6.00)
  • GF Value™: ¥21.63 vs. price of ¥17.55 (18.9% below fair value)
  • GF Score™: 61/100 with 2 warning signs
  • Industry Position: 40% above the Drug Manufacturers median (#79 of 979)

No single metric tells the full story. See the SHSE:600079 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Humanwell Healthcare (Group) Co Business Description

Address No. 666, Gaoxin Avenue, East Lake High-tech Development Zone, Hubei Province, Wuhan, CHN, 430075
Humanwell Healthcare (Group) Co Ltd is a China-based integrated healthcare solution provider. It provides medicinal products including fertility-regulating drugs, Uyghur medicine, traditional Chinese medicine, medical devices, over-the-counter medicines, anti-infection drugs, herbal medicines, and biological products. The organization has a business presence in China and other international countries.
61GF Score

Get the complete analysis for SHSE:600079

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥17.55
Price
¥21.63
GF Value